| Title | The search for new COX-2 inhibitors: a review of 2002 - 2008 patents. | | Author(s) | Ramalho TC, Rocha MV, da Cunha EF, Freitas MP | | Institution | Universidade Federal de Lavras, Departamento de Química, Campus universitário- UFLA, 37200-000 - Lavras, MG - Brazil +55 35 3822 1891 ; +55 35 3829 1271 ; teo@ufla.br. | | Source | Expert Opin Ther Pat 2009 Jun 29. | | Abstract | Background: Two COX isoenzymes are known, COX-1 and COX-2, for which the main inhibitors are the NSAIDs. The common anti-inflammatory drugs (such as aspirin, ibuprofen and naproxen) all act by blocking the action of both the COX-1 and COX-2 enzymes. The COX-2 inhibitors represent a new class of drugs that do not affect COX-1 but selectively block COX-2. This selective action provides the benefits of reducing inflammation without irritating the stomach and cardiovascular effects.
Objective: This review focuses on patents published in the field during 2002 - 2008, paying particular attention to promising COX-2 inhibitors.
Conclusion: Structural analogues of the COX-2 inhibitors celecoxib and valdecoxib, and novel potential pyridazine, triazole, indole and thione derivatives emerge as promising leads for the treatment of inflammation, pain and other diseases. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19563267 |
|
